Cancer prevention by retinoids and carotenoids: Independent action on a common target

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1740, Issue 2, 2005, Pages 170-178

  Bertram, John S ^a   Vine, Alex L ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 2,6 CYCLOLYCOPENE 1,5 DIOL; 2,7,11 TRIMETHYLTETRADECAHEXAENE 1,14 DIAL; ACYCLORETINOIC ACID; ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASTAXANTHIN; BETA CAROTENE; BETA IONONE; BLOCKING AGENT; CANTHAXANTHIN; CARBOXYLIC ACID; CAROTENOID; CONNEXIN 32; CONNEXIN 43; ETICYCLIDINE; GAP JUNCTION PROTEIN; LUCIFERASE; LYCOPENE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; RETINOIC ACID RECEPTOR ANTAGONIST; RETINOID; RETINOL; RO 41 5253; RO 415253; TETRACYCLINE; TETRAHYDROTETRAMETHYLNAPHTHALENYLPROPENYLBENZOIC ACID; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; CANCER INCIDENCE; CANCER PREVENTION; CARCINOGENESIS; CELL COMMUNICATION; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DRUG HALF LIFE; GAP JUNCTION; GENE CONTROL; HUMAN; MOLECULAR MECHANICS; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPORTER GENE; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BENZOATES; CAROTENOIDS; CELL COMMUNICATION; CELL LINE; CONNEXIN 43; CONSENSUS SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROMOTER REGIONS (GENETICS); RETINOIDS;

EID: 20444399144     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2005.01.003     Document Type: Conference Paper

References (53)

1. J.S. Bertram The molecular biology of cancer Mol. Aspects Med. 21 2001 167 223
2. R. Doll, and R. Peto The causes of cancer 1981 Oxford University Press
3. P. Vineis, M. Alavanja, P. Buffler, E. Fontham, S. Franceschi, Y.T. Gao, P.C. Gupta, A. Hackshaw, E. Matos, J. Samet, F. Sitas, J. Smith, L. Stayner, K. Straif, M.J. Thun, H.E. Wichmann, A.H. Wu, D. Zaridze, R. Peto, and R. Doll Tobacco and cancer: recent epidemiological evidence J. Natl. Cancer Inst. 96 2004 99 106
4. L.J. Marnett, and R.N. DuBois COX-2: a target for colon cancer prevention Annu. Rev. Pharmacol. Toxicol. 42 2002 55 80
5. J.S. Bertram, L.N. Kolonel, and F.L. Meyskens Rationale and strategies for chemoprevention of cancer in humans Cancer Res. 47 1987 3012 3031
6. C.A. Reznikoff, J.S. Bertram, D.W. Brankow, and C. Heidelberger Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division Cancer Res. 33 1973 2339 2349
7. C.H. Heidelberger, A.W. Freeman, R.J. Pienta, A. Sivak, J.S. Bertram, B.C. Casto, V.C. Dunkel, M.W. Francis, T. Kakunaga, J.B. Little, and L.M. Schechtman Cell transformation by chemicals: a review and analysis of the literature Mutat. Res. 114 1983 283 385
8. A. Pung, J.E. Rundhaug, C.N. Yoshizawa, and J.S. Bertram β-Carotene and canthaxanthin inhibit chemically- and physically-induced neoplastic transformation in 10T1/2 cells Carcinogenesis 9 1988 1533 1539
9. R. Merriman, and J.S. Bertram Reversible inhibition by retinoids of 3-methylcholanthrene-induced neoplastic transformation in C3H10T1/2 cells Cancer Res. 39 1979 1661 1666
10. J.S. Bertram, J.E. Rundhaug, and A. Pung Carotenoids inhibit chemically- and physically-induced neoplastic transformation during the post-initiation phase of carcinogenesis K.N. Prasad F.L. Meyskens Nutrients and cancer prevention 1990 Humana Press Clifton 99 111
11. L.-X. Zhang, R.V. Cooney, and J.S. Bertram Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action Carcinogenesis 12 1991 2109 2114
12. M.Z. Hossain, L.R. Wilkens, P.P. Mehta, W.R. Loewenstein, and J.S. Bertram Enhancement of gap junctional communication by retinoids correlates with their ability to inhibit neoplastic transformation Carcinogenesis 10 1989 1743 1748
13. J.S. Bertram, A. Pung, M. Churley, T.J.I. Kappock, L.R. Wilkins, and R.V. Cooney Diverse carotenoids protect against chemically induced neoplastic transformation Carcinogenesis 12 1991 671 678
14. A.M. Simon, and D.A. Goodenough Diverse functions of vertebrate gap junctions Trends Cell Biol. 8 1998 477 483
15. M. Neveu, and J.S. Bertram Gap junctions and neoplasia Advances in Cellular and Molecular Biology 2000 JAI Press Greenwich, CT 221 262
16. T.J. King, L.H. Fukushima, A.D. Hieber, K.A. Shimabukuro, W.A. Sakr, and J.S. Bertram Reduced levels of connexin43 in cervical dysplasia: inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression Carcinogenesis 21 2000 1097 1109
17. V. Krutovskikh, and H. Yamasaki Connexin gene mutations in human genetic diseases Mutat. Res. 462 2000 197 207
18. L.W. Tan, T. Bianco, and A. Dobrovic Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer Carcinogenesis 23 2002 231 236
19. T.J. King, L.H. Fukushima, T.A. Donlon, A.D. Hieber, K.A. Shimabukuro, and J.S. Bertram Correlation between growth control, neoplastic potential and endogenous connexin43 expression in HeLa cell lines: implications for tumor progression Carcinogenesis 21 2000 311 315
20. S.W. Lee, C. Tomasetto, and R. Sager Positive selection of candidate tumor-suppressor genes by subtractive hybridization Proc. Natl. Acad. Sci. U. S. A. 88 1991 2825 2829
21. M. Mesnil Connexins and cancer Biol. Cell 94 2002 493 500
22. M. Yeager Structure of cardiac gap junction intercellular channels J. Struct. Biol. 121 1998 231 245
23. T.J. King, L.H. Fukushima, Y. Yasui, P.D. Lampe, and J.S. Bertram Inducible expression of the gap junction protein connexin43 decreases the neoplastic potential of HT-1080 human fibrosarcoma cells in vitro and in vivo Mol. Carcinog. 35 2002 29 41
24. A.L. Vine, and J.S. Bertram Cancer chemoprevention by connexins Cancer Metastasis Rev. 21 2002 199 216
25. Y. Omori, M.L. Zaidan Dagli, K. Yamakage, and H. Yamasaki Involvement of gap junctions in tumor suppression: analysis of genetically-manipulated mice Mutat. Res. 477 2001 191 196
26. T.J. King, and P.D. Lampe Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation Carcinogenesis 25 2004 669 680
27. J.L. Avanzo, M. Mesnil, F.J. Hernandez-Blazquez, I.I. Mackowiak, C.M. Mori, T.C. Da Silva, S.C. Oloris, A.P. Garate, S.M. Massironi, H. Yamasaki, and M.L. Dagli Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43 Carcinogenesis 25 2004 1973 1982
28. O. Kucuk, F.H. Sarkar, W. Sakr, Z. Djuric, M.N. Pollak, F. Khachik, Y.W. Li, M. Banerjee, D. Grignon, J.S. Bertram, J.D. Crissman, E.J. Pontes, and D.P. Wood Jr. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy Cancer Epidemiol. Biomark. Prev. 10 2001 861 868
29. H.S. Kim, P. Bowen, L. Chen, C. Duncan, L. Ghosh, R. Sharifi, and K. Christov Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma Nutr. Cancer 47 2003 40 47
30. M.S. Ansari, and N.P. Gupta A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer BJU Int. 92 2003 375 378
31. V. Venkateswaran, N.E. Fleshner, L.M. Sugar, and L.H. Klotz Antioxidants block prostate cancer in lady transgenic mice Cancer Res. 64 2004 5891 5896
32. M. Karas, H. Amir, D. Fishman, M. Danilenko, S. Segal, A. Nahum, A. Koifmann, Y. Giat, J. Levy, and Y. Sharoni Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells Nutr. Cancer 36 2000 101 111
33. U. Siler, L. Barella, V. Spitzer, J. Schnorr, M. Lein, R. Goralczyk, and K. Wertz Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model FASEB J. 18 2004 1019 1021
34. L.A. Mucci, R. Tamimi, P. Lagiou, A. Trichopoulou, V. Benetou, E. Spanos, and D. Trichopoulos Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int. 87 2001 814 820
35. J.M. Seargent, E.A. Yates, and J.H. Gill GW9662, a potent antagonist of PPAR{gamma}, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPAR{gamma} agonist rosiglitazone, independently of PPAR{gamma} activation Br. J. Pharmacol. 143 2004 933 937
36. P. Tontonoz, R.A. Graves, A.I. Budavari, H. Erdjument-Bromage, M. Lui, E. Hu, P. Tempst, and B.M. Spiegelman Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha Nucleic Acids Res. 22 1994 5628 5634
37. P.F. Egea, A. Mitschler, N. Rochel, M. Ruff, P. Chambon, and D. Moras Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid EMBO J. 19 2000 2592 2601
38. S. Mailfait, E. Thoreau, D. Belaiche, and B.S. Formstecher And Critical role of the H6-H7 loop in the conformational adaptation of all-trans retinoic acid and synthetic retinoids within the ligand-binding site of RARalpha J. Mol. Endocrinol. 24 2000 353 364
39. D.L. Newton, W.R. Henderson, and M.B. Sporn Structure-activity relationships of retinoids in hamster tracheal organ culture Cancer Res. 40 1980 3413 3425
40. P. Acevedo, and J.S. Bertram Liarozole potentiates the cancer chemopreventive activity of and the up-regulation of gap junctional communication and connexin43 expression by retinoic acid and β-carotene in 10T1/2 cells Carcinogenesis 16 1995 2215 2222
41. C. Kiefer, S. Hessel, J.M. Lampert, K. Vogt, M.O. Lederer, D.E. Breithaupt, and J. Von Lintig Identification and characterization of a mammalian enzyme catalyzing the asymmetric oxidative cleavage of provitamin A J. Biol. Chem. 276 2001 14110 14116
42. I. Paetau, F. Khachik, E.D. Brown, G.R. Beecher, T.R. Kramer, J. Chittams, and B.A. Clevidence Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoids in humans Am. J. Clin. Nutr. 68 1998 1187 1195
43. J.S. Bertram, T.J. King, L. Fukushima, and F. Khachik Enhanced activity of an oxidation product of lycopene found in tomato products and human serum relevent to cancer prevention K.S. Sen H. Sies P.A. Baeuerle Antioxidant and redox regulation of genes 2000 Academic Press San Diego 410 424
44. O. Aust, N. Ale-Agha, L. Zhang, H. Wollersen, H. Sies, and W. Stahl Lycopene oxidation product enhances gap junctional communication Food Chem. Toxicol. 41 2003 1399 1407
45. W. Stahl, J. Von Laar, H.D. Martin, T. Emmerich, and H. Sies Stimulation of gap junctional communication: comparison of acyclo-retinoic acid and lycopene Arch. Biochem. Biophys. 373 2000 271 274
46. L.-X. Zhang, R.V. Cooney, and J.S. Bertram Carotenoids up-regulate connexin43 gene expression independent of their pro-vitamin A or antioxidant properties Cancer Res. 52 1992 5707 5712
47. W. Stahl, M. Hanusch, and H. Sies 4-Oxo-retinoic acid is generated from its precursor canthaxanthin and enhances gap junctional communication in 10T1/2 cells Adv. Exp. Med. Biol. 387 1996 121 128
48. G.D. Carystinos, M. Kandouz, M.A. Alaoui-Jamali, and G. Batist Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence Mol. Pharmacol. 63 2003 821 831
49. A.L. Vine, Y.M. Leung, J.S. Bertram, Transcriptional regulation of connexin 43 expression by retinoids and carotenoids: similarities and differences, Mol. Carcinog. (in press).
50. M. Rogers, J.M. Berestecky, M.Z. Hossain, H.M. Guo, R. Kadle, B.J. Nicholson, and J.S. Bertram Retinoid-enhanced gap junctional communication is achieved by increased levels of connexin 43 mRNA and protein Mol. Carcinog. 3 1990 335 343
51. L.M. Hix, A.L. Vine, S.F. Lockwood, and J.S. Bertram Retinoids and carotenoids as cancer chemopreventive agents: role of up regulated gap junctional communication L. Packer K. Kraemer U.C. Obermueller-Jevic H. Sies Carotenoids and retinoids 2004 AOCS Press Champaign, IL 182 203
52. J.S. Bertram A.E. Meier Cellular communication via gap junctions 2000 Science and Medicine Philadelphia 32 41
53. A.L. Vine, J.S. Bertram, Upregulation of Connexin 43 by retinoids but not by non-pro-vitamin A carotenoids requires RARs, (submitted for publication).